Pressrelease: Concord Neonatal to expand sales internationally
Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is…
Pressrelease: Intelligent ultrasound technique for diagnosing prostate cancer
Tilburg – 18 january 2021 – CbusineZ, the venture capital investor liaised to health insurer CZ, will together with a group of private investors,…
NLC concludes Framework Agreement with patent attorny firm De Vries & Metman
NLC has concluded a Framework Agreement with Amsterdam based patent attorney firm De Vries & Metman for their patent and IP protection services. “The best IP should be…
NLC’s current venture portfolio
NLC’s current venture portfolio
Inventor Brochure
Read the Inventor Brochure
NLC successfully closes the new Stepping Stone Fund to finance 40 promising new HealthTech ventures
Amsterdam, Tuesday 15 December 2020 – Today, NLC closed the first round of the new NLC Stepping Stone Fund. NLC – the European HealthTech…
Rob ten Hoedt joins Supervisory Board
We are pleased to announce that Rob ten Hoedt has agreed to join NLC’s Supervisory Board per December 1st 2020. Rob is Executive Vice…
Bridging The Valley:
INNOVATIVE APPROACHES TO SOLVING THE EARLY-STAGE FUNDING CRISIS Over the past 5 years, NLC has been able to secure (seed) financing for over 40…
NLC and Medtech Europe publish reflection paper on how to improve the innovative landscape of Europe in health tech
MedTech Europe in collaboration with NLC published a reflection paper outlining how Europe can provide a more attractive landscape for Innovation in health tech….